Your mouth is one of the most overlooked windows into your long-term health. Campylobacter rectus (C. rectus) is one of the bacteria that lives in the spaces between teeth and gums, and when it takes hold, it is associated with much more than bad breath or bleeding gums.
Higher levels of this bacterium, and higher blood antibody responses to it, have been linked in human studies to gum disease, higher blood pressure, tiny bleeds in the brain after stroke, and increased risk of Alzheimer's disease. Checking whether it is present in your saliva gives you a concrete read on the bacterial state of your mouth.
This test detects C. rectus in a saliva sample. The bacterium is anaerobic, meaning it grows in low-oxygen environments like the deep pockets that form between gums and teeth in periodontal disease. It is a member of what oral microbiologists call the "orange complex," a group of disease-associated species that tend to appear together and pave the way for the more aggressive "red complex" bacteria most linked to severe gum destruction.
This is an exploratory marker. There are no universally agreed clinical cutpoints for what level of C. rectus in saliva is "safe" versus "high." Research studies have used different yardsticks, from the percentage of total bacteria growing in plaque samples to blood antibody levels, and each laboratory may report results slightly differently. The test is best used as part of a broader oral microbiome panel and tracked over time, not as a stand-alone diagnosis.
C. rectus is one of the most consistent bacterial signatures of unhealthy gums. It is found at higher levels in early and established periodontitis compared with healthy gums or simple gingivitis, and shifts in its abundance appear to track with shifts in the broader oral microbial community as disease progresses.
How common is it? In a retrospective surveillance study of 7,804 German patients with periodontitis, C. rectus was detected in roughly 3 out of 4 cases. In a separate study of 76 postmenopausal women, it was found in nearly all participants. It has also been detected in about 23% of primary root canal infections, suggesting it can travel from gum pockets into the tooth itself.
What this means for you: a positive result for C. rectus is not by itself proof of gum disease, but it is a reasonable prompt to ask your dentist about periodontal pocket measurements, bleeding on probing, and whether a deeper cleaning is warranted. If you already have gum disease, tracking this marker over time can show whether treatment is shifting your oral ecosystem in the right direction.
The most striking systemic link comes from a large analysis of older Americans tracked for up to 26 years through the NHANES III survey linked to Medicare and death records. In adults aged 65 and older, a blood antibody signature loading heavily on C. rectus and Porphyromonas gingivalis was tied to about 22% higher odds of developing Alzheimer's disease for each standard deviation increase (adjusted hazard ratio 1.22, 95% CI 1.04 to 1.43). A related antibody pattern that also included C. rectus was associated with about 46% higher Alzheimer's mortality (adjusted hazard ratio 1.46, 95% CI 1.09 to 1.96).
A follow-up analysis of 1,431 adults found that this risk was further amplified when periodontal pathogen antibodies were elevated alongside Helicobacter pylori, a stomach bacterium, suggesting the two infection burdens interact.
These studies measured antibody response in blood, which is a related but different signal from the bacterium itself in saliva. The blood antibody reflects your immune system's long-term reaction to the bacterium, while the saliva test reflects current colonization. Both point toward the same underlying concern: chronic exposure to this pathogen is a plausible contributor to long-term brain health.
In a study of 639 acute stroke patients, those with positive blood antibodies to C. rectus had roughly twice the odds of having cerebral microbleeds, the tiny brain hemorrhages visible on MRI that signal damage to small blood vessels and increase risk of future stroke and cognitive decline.
In the same line of research, a NHANES analysis of 7,928 adults found that antibodies to C. rectus were among the strongest oral predictors of higher systolic and diastolic blood pressure, and of uncontrolled hypertension. Again, these studies measured immune response in blood rather than the bacterium in saliva, but the chain of reasoning is consistent: oral colonization triggers immune activation, which in turn appears to track with vascular damage.
In a study of 63 Hispanic Americans, those with type 2 diabetes had higher levels of Campylobacter species at their periodontal sites and elevated serum antibodies to C. rectus compared with non-diabetic controls. The combination suggests that diabetes may amplify both the colonization and the immune reaction to this bacterium, which could partly explain why people with diabetes are at higher risk for severe gum disease.
C. rectus normally stays in the mouth, but case reports describe it spreading to cause pneumonia, femoral osteomyelitis (bone infection), and bloodstream infections, almost always in people with poor oral hygiene or chronic periodontitis. These events are rare, but they are a reminder that the oral microbiome does not stay perfectly contained, particularly when gum disease is advanced.
There are no universally agreed clinical reference ranges for C. rectus in saliva. The ranges below come from research studies using different sample types and methods. They are illustrative orientation only, not clinical targets, and your lab will likely report different numbers and units. Sampling site (saliva, subgingival plaque, or blood antibody) and lab method matter enormously.
| Context | Threshold used | What it suggested |
|---|---|---|
| Subgingival plaque culture | At or above 2.0% of total cultivable flora | Higher risk of periodontitis recurrence in maintenance patients |
| Blood antibody (ELISA units) | Above mean plus one standard deviation, log scale | Classified as "C. rectus positive," linked to cerebral microbleeds |
| Saliva PCR copy counts | No standardized cutpoint | Higher copy counts seen in gingivitis and periodontitis vs healthy |
Source: Rams et al. 1996; Shiga et al. 2020; Saygun et al. 2011. For the most meaningful interpretation, compare your results within the same lab over time, and pair them with a clinical periodontal exam.
A single C. rectus measurement is a snapshot of a moving system. Bacterial populations in the mouth shift with brushing habits, flossing, professional cleanings, dietary changes, smoking, and even illness. One reading tells you what is happening now. A trend tells you whether your interventions are working.
A reasonable cadence: get a baseline, retest 3 to 6 months after any major change in oral care (new hygienist, periodontal treatment, switch to electric toothbrush, smoking cessation), and then at least annually. If your baseline showed colonization and your trend is moving down alongside better gum exam findings, that is meaningful progress. If it stays elevated despite intervention, that is a signal to investigate further.
A positive C. rectus result on its own does not diagnose gum disease, but it changes what you do next. The most useful pairings are clinical and microbiological.
Salivary microbiome results can be distorted by a few common factors. Knowing them helps you avoid acting on a misleading reading.
Evidence-backed interventions that affect your Campylobacter rectus level
Campylobacter rectus is best interpreted alongside these tests.